Skip to primary navigation
Skip to main content
Contact Us
English
Français
(
French
)
To search, type and hit enter.
BIOTECanada
Membership
Become a Member
Benefits of Membership
Membership Advantage Connection
Join BIOTECanada
Member Listings
Members Only Area
BIONATION
About BIONATION
Publications
Events
2024 Gold Leaf Awards
Canada @ BIO 2024
News
BIOTECanada News
Publications
Insights Magazine
Past Issues
About
Team
Board of Directors
Ethics
Membership Criteria
Health
Partnership Program
National Biotech Accord
Who’s Hiring?
R&D Portal
Work at BIOTECanada
Policy Matters
Vaccines In Canada
Biotechnology Ecosystem
Consultations
Industry Data
Health
Rare Diseases
Canada’s Vaccine Industry Committee
Agriculture & Industrial
Member Login
News
All
Media Mentions
Member Press Releases
Press Releases
Statements & Submissions
Member Press Releases
|
Dec 05, 2024
GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture
Statements & Submissions
|
Nov 26, 2024
BIOTECanada CUSMA Consultations
Media Mentions
|
Nov 07, 2024
Three years and waiting for Canada’s made-in-Montreal COVID shot
Member Press Releases
|
Oct 30, 2024
Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
Member Press Releases
|
Oct 24, 2024
Epitopea Closes USD $31 million Pre-Series A Financing
Statements & Submissions
|
Oct 24, 2024
Building a Strategic Foresight Framework to Support System Readiness for AdvancedTherapeutic Products in Canada
Press Releases
|
Oct 09, 2024
BIOTECanada Welcomes Three New Members to its Board of Directors
Media Mentions
|
Oct 06, 2024
Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter
Member Press Releases
|
Sep 19, 2024
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster
Media Mentions
|
Sep 18, 2024
Canada’s biotech carpe diem
Member Press Releases
|
Sep 16, 2024
Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement Québec
Statements & Submissions
|
Sep 11, 2024
BIOTECanada PMPRB Consultation
Statements & Submissions
|
Sep 11, 2024
Vaccine Industry Committee (VIC): PMPRB Consultation
Member Press Releases
|
Sep 10, 2024
Entos led UofA-Dalhousie study published in Cell – “Safe and Effective Delivery of DNA and RNA Using PLV”
Member Press Releases
|
Sep 05, 2024
HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing
Member Press Releases
|
Sep 04, 2024
Feldan Therapeutics completes a US$ 21 Million series b financing co-led by Genesys Capital and Fonds de solidarité FTQ
Statements & Submissions
|
Sep 03, 2024
Budget 2024 Capital Gains Tax Increase Consultation
Member Press Releases
|
Aug 27, 2024
Find Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Study of FTX-101 for the Treatment of Chronic Optic Neuropathy
Statements & Submissions
|
Aug 09, 2024
Modernize NSNR
Statements & Submissions
|
Aug 02, 2024
BIOTECanada’s 2025 Pre-Budget Submission
Statements & Submissions
|
Aug 01, 2024
Vaccine Industry Committee (VIC): Pre-Budget Submission
Statements & Submissions
|
Jul 24, 2024
BIOTECanada’s response to bilateral agreements between the Government of Canada and the Province of British Columbia to improve patient access to drugs for rare diseases
Press Releases
|
Jun 03, 2024
BIOTECanada Opens the Canada Pavilion at BIO International Convention
Press Releases
|
May 31, 2024
BIOTECanada Hosts Annual General Meeting and Announces New Chair of the Board of Directors
Statements & Submissions
|
May 29, 2024
Message to Members of BIOTECanada from the Board of Directors
Statements & Submissions
|
May 27, 2024
BIOTECanada’s Response to SR&ED Phase 2
Statements & Submissions
|
May 25, 2024
BIOTECanada’s submission on Bill C64 An Act respecting pharmacare
Media Mentions
|
May 01, 2024
Embracing regulatory ambition to shape Canada’s future in health-care innovation
Media Mentions
|
Apr 25, 2024
Capital gains tax changes are a setback for Canadian biotech competitiveness
Media Mentions
|
Apr 22, 2024
A Capital Gains Tax Increase? Now?
Press Releases
|
Apr 17, 2024
2024 Federal Budget Recognizes the Critical Role of Canada’s Biotech Industry
Statements & Submissions
|
Apr 15, 2024
BIOTECanada’s Submission on Patent Box (Creating a Patent Box Regime)
Statements & Submissions
|
Apr 15, 2024
BIOTECanada’s Submission on SRED Consultation
Media Mentions
|
Apr 02, 2024
First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists
Media Mentions
|
Mar 14, 2024
Poutine and proteins: Biotech in Canada
Statements & Submissions
|
Mar 04, 2024
BIOTECanada Statement on Federal Announcement of Pharmacare Legislation-Bill C-64
Media Mentions
|
Feb 20, 2024
Investment Reports
Press Releases
|
Sep 29, 2023
Celebrating the Best in Canadian Biotech: BIOTECanada Announces 2023 Gold Leaf Award Winners
Media Mentions
|
Sep 11, 2023
Biotech sector is having a generational moment in Canada
Press Releases
|
Jun 27, 2023
BIOTECanada Announces Addition of Directors to Board of Directors
Media Mentions
|
Apr 27, 2023
Time to Recapture Momentum for Vaccines and Immunization
Press Releases
|
Mar 22, 2023
BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
Statements & Submissions
|
Mar 16, 2023
BIOTECanada Welcomes New Council of Expert Advisors
Media Mentions
|
Oct 13, 2022
How Canadian biotech can lead in the solutions of the future
Press Releases
|
Sep 28, 2022
Canadian Biotech Industry Recognizes Top Performers
Media Mentions
|
Sep 27, 2022
Canada’s biotech ecosystem at an inflection point
Media Mentions
|
Sep 22, 2022
How to Grow Canada’s Biotech Sector
Press Releases
|
May 31, 2022
BIOTECanada Announces Addition of Directors to Board of Directors
Press Releases
|
Apr 20, 2022
Statement on Federal Decision on Regulations Governing PMPRB
Press Releases
|
Apr 08, 2022
BIOTECanada Welcomes Federal Budget’s Commitment to Canadian Biotech Industry
Press Releases
|
Jan 05, 2022
BIOTECanada is Supportive of the Implementation Delay for Changes to the PMPRB Recently Announced by the Government of Canada
Press Releases
|
Nov 28, 2021
BIOTECanada Supports Federal Government’s Commitment to Biomanufacturing Sector
Press Releases
|
Oct 26, 2021
BIOTECanada Welcomes Federal Cabinet Announcement
Media Mentions
|
Sep 21, 2021
The Canadian biotechnology industry’s moment
Press Releases
|
Sep 21, 2021
BIOTECanada Congratulates Liberal Party on Election Victory
Press Releases
|
Jul 28, 2021
BIOTECanada Supports Government of Canada’s Biomanufacturing Strategy
Press Releases
|
Jun 29, 2021
Statement From BIOTECanada Regarding PMPRB Implementation Delay
Press Releases
|
Jun 08, 2021
Canadian Biotech Industry Ready to Wave the Flag at BIO Digital
Press Releases
|
Jun 03, 2021
BIOTECanada Board Announces Addition of Directors and New Chair
Media Mentions
|
Apr 30, 2021
Significant Investment For Canadian Bio-Manufacturing
Press Releases
|
Apr 23, 2021
Proposed TRIPS Waiver for Intellectual Property
Press Releases
|
Apr 19, 2021
Federal Budget Recognizes Strategic Importance of Canada’s Biotech Sector
Press Releases
|
Apr 15, 2021
BIOTECanada and Cognit.ca launch initiative to help biotechnology industry mobilize university and hospital research
Press Releases
|
Apr 09, 2021
BIOTECanada Outlines the Vast Economic Recovery Opportunity for Canada in the Upcoming Federal Budget
Press Releases
|
Mar 31, 2021
BIOTECanada Supports Sanofi Announcement Investing in Canadian Biomanufacturing Capacity
Media Mentions
|
Jan 12, 2021
Spotlight on biotech in Canada
Media Mentions
|
Nov 20, 2020
Holistic Policy Needed to Grow Biotech in Canada
Media Mentions
|
Nov 20, 2020
Vaccine Manufacturing in Canada
Media Mentions
|
Nov 07, 2024
Three years and waiting for Canada’s made-in-Montreal COVID shot
Media Mentions
|
Oct 06, 2024
Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter
Media Mentions
|
Sep 18, 2024
Canada’s biotech carpe diem
Media Mentions
|
May 01, 2024
Embracing regulatory ambition to shape Canada’s future in health-care innovation
Media Mentions
|
Apr 25, 2024
Capital gains tax changes are a setback for Canadian biotech competitiveness
Media Mentions
|
Apr 22, 2024
A Capital Gains Tax Increase? Now?
Media Mentions
|
Apr 02, 2024
First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists
Media Mentions
|
Mar 14, 2024
Poutine and proteins: Biotech in Canada
Media Mentions
|
Feb 20, 2024
Investment Reports
Media Mentions
|
Sep 11, 2023
Biotech sector is having a generational moment in Canada
Media Mentions
|
Apr 27, 2023
Time to Recapture Momentum for Vaccines and Immunization
Media Mentions
|
Oct 13, 2022
How Canadian biotech can lead in the solutions of the future
Media Mentions
|
Sep 27, 2022
Canada’s biotech ecosystem at an inflection point
Media Mentions
|
Sep 22, 2022
How to Grow Canada’s Biotech Sector
Media Mentions
|
Sep 21, 2021
The Canadian biotechnology industry’s moment
Media Mentions
|
Apr 30, 2021
Significant Investment For Canadian Bio-Manufacturing
Media Mentions
|
Jan 12, 2021
Spotlight on biotech in Canada
Media Mentions
|
Nov 20, 2020
Holistic Policy Needed to Grow Biotech in Canada
Media Mentions
|
Nov 20, 2020
Vaccine Manufacturing in Canada
Member Press Releases
|
Dec 05, 2024
GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture
Member Press Releases
|
Oct 30, 2024
Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
Member Press Releases
|
Oct 24, 2024
Epitopea Closes USD $31 million Pre-Series A Financing
Member Press Releases
|
Sep 19, 2024
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster
Member Press Releases
|
Sep 16, 2024
Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement Québec
Member Press Releases
|
Sep 10, 2024
Entos led UofA-Dalhousie study published in Cell – “Safe and Effective Delivery of DNA and RNA Using PLV”
Member Press Releases
|
Sep 05, 2024
HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing
Member Press Releases
|
Sep 04, 2024
Feldan Therapeutics completes a US$ 21 Million series b financing co-led by Genesys Capital and Fonds de solidarité FTQ
Member Press Releases
|
Aug 27, 2024
Find Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Study of FTX-101 for the Treatment of Chronic Optic Neuropathy
Press Releases
|
Oct 09, 2024
BIOTECanada Welcomes Three New Members to its Board of Directors
Press Releases
|
Jun 03, 2024
BIOTECanada Opens the Canada Pavilion at BIO International Convention
Press Releases
|
May 31, 2024
BIOTECanada Hosts Annual General Meeting and Announces New Chair of the Board of Directors
Press Releases
|
Apr 17, 2024
2024 Federal Budget Recognizes the Critical Role of Canada’s Biotech Industry
Press Releases
|
Sep 29, 2023
Celebrating the Best in Canadian Biotech: BIOTECanada Announces 2023 Gold Leaf Award Winners
Press Releases
|
Jun 27, 2023
BIOTECanada Announces Addition of Directors to Board of Directors
Press Releases
|
Mar 22, 2023
BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
Press Releases
|
Sep 28, 2022
Canadian Biotech Industry Recognizes Top Performers
Press Releases
|
May 31, 2022
BIOTECanada Announces Addition of Directors to Board of Directors
Press Releases
|
Apr 20, 2022
Statement on Federal Decision on Regulations Governing PMPRB
Press Releases
|
Apr 08, 2022
BIOTECanada Welcomes Federal Budget’s Commitment to Canadian Biotech Industry
Press Releases
|
Jan 05, 2022
BIOTECanada is Supportive of the Implementation Delay for Changes to the PMPRB Recently Announced by the Government of Canada
Press Releases
|
Nov 28, 2021
BIOTECanada Supports Federal Government’s Commitment to Biomanufacturing Sector
Press Releases
|
Oct 26, 2021
BIOTECanada Welcomes Federal Cabinet Announcement
Press Releases
|
Sep 21, 2021
BIOTECanada Congratulates Liberal Party on Election Victory
Press Releases
|
Jul 28, 2021
BIOTECanada Supports Government of Canada’s Biomanufacturing Strategy
Press Releases
|
Jun 29, 2021
Statement From BIOTECanada Regarding PMPRB Implementation Delay
Press Releases
|
Jun 08, 2021
Canadian Biotech Industry Ready to Wave the Flag at BIO Digital
Press Releases
|
Jun 03, 2021
BIOTECanada Board Announces Addition of Directors and New Chair
Press Releases
|
Apr 23, 2021
Proposed TRIPS Waiver for Intellectual Property
Press Releases
|
Apr 19, 2021
Federal Budget Recognizes Strategic Importance of Canada’s Biotech Sector
Press Releases
|
Apr 15, 2021
BIOTECanada and Cognit.ca launch initiative to help biotechnology industry mobilize university and hospital research
Press Releases
|
Apr 09, 2021
BIOTECanada Outlines the Vast Economic Recovery Opportunity for Canada in the Upcoming Federal Budget
Press Releases
|
Mar 31, 2021
BIOTECanada Supports Sanofi Announcement Investing in Canadian Biomanufacturing Capacity
Statements & Submissions
|
Nov 26, 2024
BIOTECanada CUSMA Consultations
Statements & Submissions
|
Oct 24, 2024
Building a Strategic Foresight Framework to Support System Readiness for AdvancedTherapeutic Products in Canada
Statements & Submissions
|
Sep 11, 2024
BIOTECanada PMPRB Consultation
Statements & Submissions
|
Sep 11, 2024
Vaccine Industry Committee (VIC): PMPRB Consultation
Statements & Submissions
|
Sep 03, 2024
Budget 2024 Capital Gains Tax Increase Consultation
Statements & Submissions
|
Aug 09, 2024
Modernize NSNR
Statements & Submissions
|
Aug 02, 2024
BIOTECanada’s 2025 Pre-Budget Submission
Statements & Submissions
|
Aug 01, 2024
Vaccine Industry Committee (VIC): Pre-Budget Submission
Statements & Submissions
|
Jul 24, 2024
BIOTECanada’s response to bilateral agreements between the Government of Canada and the Province of British Columbia to improve patient access to drugs for rare diseases
Statements & Submissions
|
May 29, 2024
Message to Members of BIOTECanada from the Board of Directors
Statements & Submissions
|
May 27, 2024
BIOTECanada’s Response to SR&ED Phase 2
Statements & Submissions
|
May 25, 2024
BIOTECanada’s submission on Bill C64 An Act respecting pharmacare
Statements & Submissions
|
Apr 15, 2024
BIOTECanada’s Submission on Patent Box (Creating a Patent Box Regime)
Statements & Submissions
|
Apr 15, 2024
BIOTECanada’s Submission on SRED Consultation
Statements & Submissions
|
Mar 04, 2024
BIOTECanada Statement on Federal Announcement of Pharmacare Legislation-Bill C-64
Statements & Submissions
|
Mar 16, 2023
BIOTECanada Welcomes New Council of Expert Advisors
